Medicare to pay for $93,000 prostate cancer drug
Wednesday, March 30, 2011 - 16:30
in Health & Medicine
(AP) -- Medicare officials said Wednesday that the program will pay the $93,000 cost of prostate cancer drug Provenge, an innovative therapy that gives men suffering from the disease an extra four months to live, on average.